ENGENSIS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87777607
Serial Number
87777607
Registration Number
5694789
Word Mark
ENGENSIS
Status
700 - Registered
Status Date
2019-03-12
Filing Date
2018-01-31
Registration Number
5694789
Registration Date
2019-03-12
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-10-02
Attorney Name
Law Office Assigned Location Code
M50
Employee Name
FIRST, VIVIAN M
Statements
Goods and Services
Chemical reagents for use in veterinary genetic testing; reagents for use in medical genetic testing; diagnostic preparations for medical purposes for detecting mutation in prion genes; preparations for medical purposes for detecting mutation in prion genes; chemical preparations for pharmaceutical purposes, namely, for painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; drugs for medical purposes, namely, prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; medicines for human purposes, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for diagnosis of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; ethical medicinal preparations, namely, pharmaceutical preparations for the treatment of painful diabetic neuropathy, neuropathy, neuromuscular disease, amyotrophic lateral sclerosis, spinal cord disease, motor neuron disease, neurodegenerative disease, critical limb ischemia, diabetic foot ulcer, ulcer, cardiovascular disease, peripheral vascular disease, peripheral arterial disease, myocardial ischemia, coronary artery disease, heart disease, arterial occlusive disease, infarction; pharmaceutical preparations for the treatment of immune system related diseases and disorders; chemical preparations for use in medical DNA analysis; genetic treatment pharmaceutical preparations
Goods and Services
Pharmaceutical research and development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research and development of vaccines and medicines; scientific research in the fields of biomedicine; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; analysis of human serum for medical research; analysis of human tissues for medical research; blood analysis services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-02-09
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-02-09
Primary Code
042
Current Trademark Owners
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
31 - 1st New Owner Entered After Registration
Address
Please log in with your Justia account to see this address.
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
DANIEL P. MULLARKEY
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2017-12-2240-2017-0165South KoreaTrue
2017-12-2240-2017-0165South KoreaTrue
Trademark Events
Event DateEvent Description
2018-02-03NEW APPLICATION ENTERED IN TRAM
2018-02-09NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-04-24TEAS VOLUNTARY AMENDMENT RECEIVED
2018-05-01ASSIGNED TO LIE
2018-05-01CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-05-01TEAS/EMAIL CORRESPONDENCE ENTERED
2018-05-14ASSIGNED TO EXAMINER
2018-05-14NON-FINAL ACTION WRITTEN
2018-05-14NON-FINAL ACTION E-MAILED
2018-05-14NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-08-23TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-08-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-08-23TEAS/EMAIL CORRESPONDENCE ENTERED
2018-08-24APPROVED FOR PUB - PRINCIPAL REGISTER
2018-09-12NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-10-02PUBLISHED FOR OPPOSITION
2018-10-02OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-11-27NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-12-21TEAS DELETE 1(B) BASIS RECEIVED
2019-02-05CASE ASSIGNED TO INTENT TO USE PARALEGAL
2018-12-21NOTICE OF ALLOWANCE CANCELLED
2019-02-051(B) BASIS DELETED; PROCEED TO REGISTRATION
2019-03-12REGISTERED-PRINCIPAL REGISTER
2019-05-10REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
2019-06-19AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP